Assets acquired include all of A.M. Surgical's endoscopic soft tissue release products for the foot and ankle market, which consist of the AM(TM) EPF (plantar fascia release), AM(TM) UDIN (interdigital nerve decompression) and AM(TM) EGR (gastrocnemius release) Systems. These three systems address the decompression and soft tissue release procedures most commonly performed by foot and ankle surgeons. Wright will continue to offer the AM(TM) foot and ankle tissue release systems.
John T. Treace, Vice President of Marketing for Wright's extremity products, said, The A.M. Surgical product line is highly complementary to our industry leading line of reconstructive and biologic products for flatfoot corrective surgery. We are very pleased that we have obtained definitive control of this innovative technology platform.